Andrographolide is an Alternative Treatment to Overcome Resistance in ER-Positive Breast Cancer via Cholesterol Biosynthesis Pathway

por Rajaratinam, Harishini, Nafi, Siti Norasikin Mohd
Publicado 2019

Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives

por Rajaratinam, Harishini, Mokhtar, Noor Fatmawati, Asma-Abdullah, Nurul, Fuad, Wan Ezumi Mohd
Publicado 2022

Passage Number of 4T1 Cells Influences the Development of Tumour and the Progression of Metastasis in 4T1 Orthotopic Mice

por Rajaratinam, Harishini, Rasudin, Nur Syahmina, Safuan, Sabreena, Abdullah, Nurul Asma, Mokhtar, Noor Fatmawati, Mohd Fuad, Wan Ezumi
Publicado 2022

Breast cancer therapy affects the expression of antineonatal Nav1.5 antibodies in the serum of patients with breast cancer

por Rajaratinam, Harishini, Rasudin, Nur Syahmina, Al Astani, Tengku Ahmad Damitri, Mokhtar, Noor Fatmawati, Yahya, Maya Mazuwin, Wan Zain, Wan Zainira, Asma-Abdullah, Nurul, Mohd Fuad, Wan Ezumi
Publicado 2021